NCT04837482View on ClinicalTrials.gov

A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions
Presbyopia
Interventions
DRUG

AGN-190584

Topical eyedrop

DRUG

Vehicle

Topical eyedrop

Trial Locations (1)

4059

School of Optometry and Vision Science, Queensland University of Technology /ID# 226378, Brisbane

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY